| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |